Calendar Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 13:56:38 2026-01-16 EST			5-day change	1st Jan Change
82.48 ^USD	-2.68%		+2.63%	-5.74%

01-13	Protagonist Therapeutics, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 08:15 AM
01-05	Takeda and Protagonist Announce Submission of New Drug Application for Rusfertide for Treatment of Polycythemia Vera	CI

Chart calendar Protagonist Therapeutics, Inc.

44e217666651acc9f068e0b937409a7.frvsijyTSFl5MPj4SzFpimL7evk5L8xSOdvbxe4OPuo.C9ndu1-kEGAjXpO0LWgjxVaVAqFdbKZiAZ6_qtxeE6kW-ZW6CvJwbAl9iw~0a0d2a099f4f66833f213d8189a25479

Upcoming events on Protagonist Therapeutics, Inc.

2026-03-17	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-05-05	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-08-11	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-11-04	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Protagonist Therapeutics, Inc.

2026-01-13	J.P. Morgan Healthcare Conference
2025-12-08	American Society of Hematology Meeting - Publication No: 5587
2025-12-08	American Society of Hematology Meeting - Publication No: 5588
2025-12-07	American Society of Hematology Meeting - Publication Number: 3810
2025-12-06	American Society of Hematology Meeting - Publication Number: 81
2025-11-06	Q3 2025 Earnings Release
2025-10-07	United European Gastroenterology Conference
2025-09-15	Bank of America World Medical Innovation Forum
2025-09-09	H.C. Wainwright Global Investment Conference
2025-09-03	Citi Biopharma Back to School Summit
2025-08-06	Q2 2025 Earnings Release
2025-07-20	Investor Meeting
2025-06-30	Business Update Call
2025-06-20	Annual General Meeting
2025-06-04	Jefferies Healthcare Conference
2025-06-01	American Society of Clinical Oncology Meeting
2025-03-03	Phase 3 VERIFY Study of Rusfertide Update Call
2025-02-21	Q4 2024 Earnings Release
2025-02-06	Investor Meeting - Key Opinion Leader
2025-01-14	JP Morgan Healthcare Conference

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	26,6 31,4 -15.46%	60,0 30,0 100%	434 321 35.44%	66,8	261	296
EBITDA Million USD	Released Forecast Spread	0,00 0,00 -	-92,7 -96,0 3.46%	254 179 41.74%	-147	150	-72,6
EBIT Million USD	Released Forecast Spread	-131 -125 -5.35%	-93,7 -127 26.5%	253 146 72.72%	-126	3,85	-88,5
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-127 -127 -0.41%	-79,0 -116 31.76%	279 161 73.23%	-85,9	12,0	-95,6
Net income Million USD	Released Forecast Spread	-127 -123 -3.53%	-79,0 -115 31.24%	275 170 62.31%	-102	24,4	-95,6
EPS USD	Released Forecast Spread	-2,60 -2,49 -4.44%	-1,39 -2,02 31.28%	4,23 2,52 67.93%	-1,59	0,66	-1,40
Announcement Date		15/03/23	27/02/24	21/02/25	-

Quarterly results

Fiscal Period	September	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread	255 120 112.46%	4,17 6,67 -37.5%	4,68 1,81 157.93%	171 56,6 201.23%	28,3 30,4 -6.97%	5,55 8,32 -33.32%	4,71 4,14 13.92%	34,9	18,0	93,0	71,7	73,1
EBITDA Million USD	Released Forecast Spread	207 -38,0 643.54%	-38,6 -44,0 12.38%	-41,2 -45,0 8.4%	127 116 9.39%	-19,1 -19,0 -0.37%	-41,7 -40,1 -4%	-46,1 -45,6 -0.93%	-54,6
EBIT Million USD	Released Forecast Spread	206 36,9 458.72%	-38,8 -39,8 2.44%	-41,5 -42,2 1.87%	127 10,5 1112.31%	-19,3 -10,8 -78.32%	-42,0 -40,1 -4.72%	-46,4 -44,8 -3.58%	-18,2	-26,1	6,50	-27,3	-28,0
Earnings before Tax (EBT) Million USD	Released Forecast Spread	211 114 84.39%	-31,3 -42,9 26.99%	-33,6 -36,3 7.29%	134 6,01 2125.63%	-11,7 -30,5 61.83%	-34,6 -34,0 -1.74%	-39,3 -39,2 -0.29%	1,18	-33,2	16,9	-34,2	-22,1
Net income Million USD	Released Forecast Spread	207 39,3 427.28%	-30,6 -44,8 31.66%	-33,2 -37,4 11.2%	132 22,5 485.31%	-11,7 -6,14 -89.94%	-34,8 -36,0 3.41%	-39,3 -39,8 1.25%	-14,9	-37,9	129	-13,4	-18,8
EPS USD	Released Forecast Spread	3,26 1,19 173.04%	-0,50 -0,73 31.67%	-0,54 -0,61 11.11%	1,98 0,32 516.61%	-0,19 0,00 -8458.56%	-0,55 -0,58 5.53%	-0,62 -0,64 2.76%	-0,21	-0,53	1,30	0,53	0,22
Announcement Date		07/05/24	06/08/24	07/11/24	21/02/25	06/05/25	06/08/25	06/11/25	-	-	-	-	-

Upcoming sector events for Protagonist Therapeutics, Inc.

2026-01-19	TELIX PHARMACEUTICALS LIMITED	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-01-21	SYNGENE INTERNATIONAL LIMITED	Q3 2026 Earnings Release	Add to your calendar Google Apple ICS format
2026-01-27	LONZA GROUP AG	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-01-28	EUROFINS SCIENTIFIC SE	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-02	BIO-TECHNE CORPORATION	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-03	SUVEN LIFE SCIENCES LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-03	ONESOURCE SPECIALTY PHARMA LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-08	MEDPACE HOLDINGS, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-09	QIAGEN N.V.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-10	AZENTA, INC.	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

More events

Past sector events for Protagonist Therapeutics, Inc.

2026-01-12	SUNMAX BIOTECHNOLOGY CO., LTD.	December 2025 Sales and Revenue Release
2026-01-09	PELL BIO-MED TECHNOLOGY CO., LTD.	December 2025 Sales and Revenue Release
2026-01-08	POLARIS GROUP	December 2025 Sales and Revenue Release
2025-12-23	BRIGHT MINDS BIOSCIENCES INC.	Q4 2025 Earnings Release
2025-12-15	ABIVAX	Q3 2025 Earnings Release
2025-12-11	EVOMMUNE, INC.	Q3 2025 Earnings Release
2025-12-10	SUNMAX BIOTECHNOLOGY CO., LTD.	November 2025 Sales and Revenue Release
2025-12-10	PELL BIO-MED TECHNOLOGY CO., LTD.	November 2025 Sales and Revenue Release
2025-12-09	POLARIS GROUP	November 2025 Sales and Revenue Release
2025-12-09	BILLIONTOONE, INC.	Q3 2025 Earnings Release